| Catalog Number | GTX118085 |
| Product Name | GALNT2 antibody [N3C3]
see all 'GALNT2' products |
| Full Name | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| Synonyms | GalNAc-T2 antibody | GALNT2 antibody | polypeptide GalNAc transferase 2 antibody | UDP-GalNAc transferase 2 antibody | polypeptide N-acetylgalactosaminyltransferase 2 antibody | pp-GaNTase 2 antibody | UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2 antibody | protein-UDP acetylgalactosaminyltransferase 2 antibody | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) antibody |
| Product Description | Rabbit Polyclonal antibody to GALNT2 (UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)) |
| Background | This gene encodes polypeptide N-acetylgalactosaminyltransferase 2, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation in a cell is regulated by a repertoire of GalNAc-transferases. [provided by RefSeq] |
| Host | Rabbit |
| Clonality | Polyclonal |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 272 and 523 of GALNT2 (Uniprot ID#Q10471) |
| Antigen Species | Human |
| Species Reactivity | Human |
| Predicted Cross Reactivity Species | Mouse (97%), Rat (80%), Bovine (99%) (Note) |
| Applications | IHC (Formalin-fixed paraffin-embedded sections), Western blot. The usefulness of this product in other applications has not been determined. |
| Application Note | Suggested starting dilutions are as follows: WB: 1:500-1:3000, IHC-P: 1:100-1:1000 [suggested antigen retrieval using heat mediated 10mM Citrate buffer (pH6.0) or Tris-EDTA buffer (pH8.0)]. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. |
| Positive Controls | NT2D1 | IMR32 |
| Predicted Target Size(KDa) | 65 (Note) |
| Cellular Localization | Golgi apparatus | Golgi stack membrane; Single-pass type II membrane protein | Secreted | |
| Form Supplied | Liquid |
| Concentration | 0.67 mg/ml |
| Purification | Purified by antigen-affinity chromatography. |
| Storage Buffer | 0.1M Tris, 0.1M Glycine, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative. |
| Storage Instruction | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Notes | For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption. |